The Alzheimer’s disease diagnostic professional market is witnessing significant growth due to the increasing prevalence of neurodegenerative disorders, rising aging populations, and growing awareness regarding early disease detection. Healthcare systems across the world are increasingly focusing on improving diagnostic accuracy and accelerating treatment intervention for patients...

The growing prevalence of bile duct cancer and the increasing demand for advanced oncology treatments are significantly contributing to the expansion of the global therapeutics market. Rising investments in cancer research, improved diagnostic technologies, and the introduction of targeted therapies are transforming the treatment landscape for cholangiocarcinoma, commonly known as bile duct...

Here's the requested HTML content following all your specifications: According to a newly published market research report by 24LifeSciences, global Dihydroxylysinonorleucine (DHLNL) ELISA Kit market was valued at USD 12.5 million in 2025 and is projected to reach USD 21.8 million by 2034, growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period 20262034....

The immobilized trypsin market is experiencing steady growth due to increasing demand for advanced proteomics research, biopharmaceutical development, and efficient protein digestion technologies. Rising adoption of mass spectrometry and automated laboratory workflows is further supporting market expansion across biotechnology and pharmaceutical sectors. The Immobilized Trypsin Market size is...

Liquid biopsy has emerged as one of the most promising innovations in modern diagnostics, offering a minimally invasive approach to detect, monitor, and manage various diseases, particularly cancer. Unlike traditional tissue biopsies, liquid biopsy analyzes biomarkers such as circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), exosomes, and other molecular components present in body...

The Middle East cancer targeted therapy market is witnessing substantial growth due to the increasing prevalence of cancer and the growing adoption of precision medicine across healthcare systems in the region. The Middle East Cancer Targeted Therapy Market size is expected to reach US$ 2,163.7 million by 2031 from US$ 1,051.4 million in 2024. The market is estimated to record a CAGR of 10.9%...